Palabras clave
Dolor
Depressión
Enfermedad de Parkinson
Rendimiento
Ejercicios
Cómo citar
Resumen
Introduccion: El placebo se considera una sustancia o procedimiento inerte que puede proporcionar un efecto positivo o negativo dependiendo de la condición en la que se aplique. Está bien documentado que el placebo promueve resultados positivos en condiciones patológicas y en condiciones de rendimiento físico. Objetivo: Por lo tanto, el objetivo de este estudio es revisar en dos sesiones documentos que han abordado: 1) el efecto placebo y nocebo aplicado a la clínica en el tratamiento de la enfermerdad de Parkinson, la depresión y el dolor, y 2) el uso de placebo como recurso ergogénico en el rendimiento físico. Metodología: Para ello, se realizó una búsqueda en la base de datos "Pubmed" y "Web of Science". Resultados y discusión: En esta revisión, discutimos cómo actúa el efecto placebo en diversas afecciones, como dolor, depresión, enfermedad de Parkinson y rendimiento físico, además de los posibles mecanismos que pueden afectar este fenómeno. Conclusión: Podemos concluir que bajo el rendimiento clínico y físico, el placebo comparte regiones cerebrales similares, que generan respuestas positivas al tratamiento.
Citas
BEEDIE, Christopher. J. et al. Placebo effects of caffeine on cycling performance. Medicine and science in sports and exercise, v. 38, n. 12, p. 2159–2164, dez. 2006.
BEEDIE, Christopher J. Placebo effects in competitive sport: qualitative data. J Sports Sci Med, v. 6, n. 1, p. 21–28, Mar, 2007.
BEEDIE, Christopher. J.; COLEMAN, Damian A.; FOAD, Abigail J. Positive and negative placebo effects resulting from the deceptive administration of an ergogenic aid. Int J Sport Nutr Exerc Metab, v. 17, n. 3, p. 259–269, Jun, 2007.
BEEDIE, Christopher. J.; FOAD, Abigail J.; COLEMAN, Damian A. Identification of Placebo Responsive Participants in 40km Laboratory Cycling Performance. Journal of Sports Science & Medicine, v. 7, n. 1, p. 166–175,Mar, 2008.
BENEDETTI, Fabrizio et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. The Journal of neuroscience : the official journal of the Society for Neuroscience, v. 23, n. 10, p. 4315–4323, maio 2003.
BENEDETTI, Fabrizio et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nature neuroscience, v. 7, n. 6, p. 587–588, jun, 2004.
BENEDETTI, Fabrizio et al. When words are painful: unraveling the mechanisms of the nocebo effect. Neuroscience, v. 147, n. 2, p. 260–271, jun, 2007.
BENEDETTI, Fabrizio. Placebo effects: from the neurobiological paradigm to translational implications. Neuron, v. 84, n. 3, p. 623–637, nov, 2014.
BENEDETTI, Fabrizio ; AMANZIO, Martina. Mechanisms of the placebo response. Pulmonary pharmacology & therapeutics, v. 26, n. 5, p. 520–523, out, 2013.
BRIETZKE, Cayque et al. Caffeine Effects on VO2MAX Test Outcomes Investigated by a Placebo Perceived-as-Caffeine Design. Nutrition and Health, dez, 2017.
CLARK, Virginia R. et al. Placebo effect of carbohydrate feedings during a 40-km cycling time trial. Med Sci Sports Exerc, v. 32, n. 9, p. 1642–1647, set, 2000.
COLLOCA, Luana.; BENEDETTI, Fabrizio. Placebos and painkillers: is mind as real as matter? Nature reviews. Neuroscience, v. 6, n. 7, p. 545–552, jul, 2005.
DE LA FUENTE-FERNANDEZ, Raúl et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science (New York, N.Y.), v. 293, n. 5532, p. 1164–1166, ago, 2001.
ELLINGSEN, Dan-Mikael et al. Placebo improves pleasure and pain through opposite modulation of sensory processing. Proceedings of the National Academy of Sciences of the United States of America, v. 110, n. 44, p. 17993–17998, out, 2013.
FOAD, Abigail J.; BEEDIE, Christopher. J.; COLEMAN, Damian A. Pharmacological and psychological effects of caffeine ingestion in 40-km cycling performance. Med Sci Sports Exerc, v. 40, n. 1, p. 158–165, jan, 2008.
FRISALDI, Elisa et al. The placebo effect on bradykinesia in Parkinson’s disease with and without prior drug conditioning. Movement disorders : official journal of the Movement Disorder Society, v. 32, n. 10, p. 1474–1478, out, 2017.
GREEN, Alexander L. et al. Identifying cardiorespiratory neurocircuitry involved in central command during exercise in humans. The Journal of physiology, v. 578, n. Pt 2, p. 605–612, jan, 2007.
KAUFMANN, Horacio et al. Stimulation of the subthalamic nucleus increases heart rate in patients with Parkinson disease. Neurology, v. 59, n. 10, p. 1657—1658, 2002.
KONG, Jian et al. Placebo analgesia: findings from brain imaging studies and emerging hypotheses. Rev Neurosci, v. 18, n. 3–4, p. 173–190, ago, 2007.
LANOTTE, Michele et al. Expectation enhances autonomic responses to stimulation of the human subthalamic limbic region. Brain, behavior, and immunity, v. 19, n. 6, p. 500–509, nov, 2005.
LEUCHTER, Andrew F. et al. Changes in brain function of depressed subjects during treatment with placebo. The American journal of psychiatry, v. 159, n. 1, p. 122–129, jan, 2002.
MAYBERG, Helen S. et al. The functional neuroanatomy of the placebo effect. The American journal of psychiatry, v. 159, n. 5, p. 728–737, maio, 2002.
MERCADO, Rodrigo et al. Expectation and the placebo effect in Parkinson’s disease patients with subthalamic nucleus deep brain stimulation. Movement disorders : official journal of the Movement Disorder Society, v. 21, n. 9, p. 1457–1461, set, 2006.
PETROVIC, Predrag et al. Placebo and opioid analgesia-- imaging a shared neuronal network. Science, v. 295, n. 5560, p. 1737–1740, mar, 2002.
PETROVIC, Predrag et al. Placebo in emotional processing--induced expectations of anxiety relief activate a generalized modulatory network. Neuron, v. 46, n. 6, p. 957–969,jun, 2005.
POLLO, Antonella et al. Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport, v. 13, n. 11, p. 1383–1386, ago, 2002.
POLLO, Antonella.; CARLINO, Elisa.; BENEDETTI, Fabrizio. The top-down influence of ergogenic placebos on muscle work and fatigue. The European journal of neuroscience, v. 28, n. 2, p. 379–388, jul. 2008.
PRICE, Donald D. et al. Placebo analgesia is accompanied by large reductions in pain-related brain activity in irritable bowel syndrome patients. Pain, v. 127, n. 1–2, p. 63–72, jan, 2007.
PRICE, Donald D.; FINNISS, Damien G..; BENEDETTI, Fabrizio. A comprehensive review of the placebo effect: recent advances and current thought. Annual review of psychology, v. 59, p. 565–590, jan, 2008.
SAUNDERS, Blair et al. Placebo in sports nutrition: a proof-of-principle study involving caffeine supplementation. Scand J Med Sci Sports, nov, 2016.
THORNTON, Judith M. et al. Electrical stimulation of the midbrain increases heart rate and arterial blood pressure in awake humans. The Journal of physiology, v. 539, n. Pt 2, p. 615–621, mar, 2002.
TROJIAN, Thomas H.; BEEDIE, Christopher J. Placebo effect and athletes. Curr Sports Med Rep, v. 7, n. 4, p. 214–217, jul, 2008.
WAGER, Tor D. et al. Placebo-induced changes in FMRI in the anticipation and experience of pain. Science, v. 303, n. 5661, p. 1162–1167, fev, 2004.
WALSH, B. Timothy et al. Placebo response in studies of major depression: variable, substantial, and growing. JAMA, v. 287, n. 14, p. 1840–1847, abr, 2002.
O periódico Conexões: Educação Física, Esporte e Saúde utiliza a licença do Creative Commons (CC), preservando assim, a integridade dos artigos em ambiente de acesso aberto.
Descargas
